SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-068491
Filing Date
2018-11-14
Accepted
2018-11-14 17:01:56
Documents
60
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-36751_110q.htm 10-Q 999901
2 EX-31.1 a18-36751_1ex31d1.htm EX-31.1 9712
3 EX-31.2 a18-36751_1ex31d2.htm EX-31.2 9688
4 EX-32.1 a18-36751_1ex32d1.htm EX-32.1 5862
5 EX-32.2 a18-36751_1ex32d2.htm EX-32.2 5871
  Complete submission text file 0001104659-18-068491.txt   4390329

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ards-20180930.xml EX-101.INS 817588
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ards-20180930.xsd EX-101.SCH 44821
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ards-20180930_cal.xml EX-101.CAL 38482
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ards-20180930_def.xml EX-101.DEF 134933
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ards-20180930_lab.xml EX-101.LAB 393797
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ards-20180930_pre.xml EX-101.PRE 271927
Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address 5941 OPTICAL COURT SAN JOSE CA 95138 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38630 | Film No.: 181184931
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1